TOP TIERMARKET NEWSWIRE
SEC Form 4 history

UROGEN PHARMA LTD (URGN) insider trades

UROGEN PHARMA LTD (URGN) insider trading activity (SEC Form 4). Over the trailing 90 days, URGN insiders filed 0 purchases totalling $0 and 4 sales totalling $3.0M — net SELLING of $3.0M. Most recent filing: Oct 9, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
4
$3.0M
Net (90d)
-$3.0M
net selling
Most recent
Oct 9, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Oct 9, 2026Degnan ChrisCFOS SaleOE—$36.69$81Kfiling
Sep 9, 2026Schoenberg MarkChief Medical OfficerS SaleOE—$42.92$37Kfiling
Sep 9, 2026Smith Jason DrewGCS SaleOE—$42.54$65Kfiling
Aug 24, 2026Schoenberg MarkChief Medical OfficerS Sale—$47.05$2.9Mfiling
Jul 10, 2026Schoenberg MarkChief Medical OfficerS Sale—$40.00$400Kfiling
Jun 24, 2026Schoenberg MarkChief Medical OfficerS Sale—$35.01$350Kfiling
Jun 9, 2026Schoenberg MarkChief Medical OfficerS SaleOE—$27.30$143Kfiling
May 11, 2026Schoenberg MarkChief Medical OfficerS Sale—$30.00$300Kfiling